Sort
64,565 grants matching “drug discovery”
Generation of a zebrafish insertional mutation library
$683,175Znomics, Inc. · R44 · FY2004 · HG
Genetic Variation and Evolution of Artemisinin Resistance
$683,171Dyann F Wirth · Harvard School Of Public Health · R01 · FY2014 · AI
Discovering mechanisms of neuroblastoma tumorigenesis to improve patient outcomes
$683,163John M Maris · Children'S Hosp Of Philadelphia · R35 · FY2017 · CA
Development of Recombinant Toxins to Treat Hematologic Malignancies
$683,093Robert Kreitman · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Bioinformatic Tools in Cancer Research
$683,082Kenneth Buetow · Division Of Basic Sciences - Nci · ZIH · FY2010 · CA
Administrative Core
$683,001Philip Frederick Sparling · Univ Of North Carolina Chapel Hill · U54 · FY2010 · AI
Towards Evidence-Based Monitoring of Low Dose Methotrexate: CIRT Ancillary Study
$682,979Daniel Hal Solomon · Brigham And Women'S Hospital · R01 · FY2015 · HL
In vivo HTS assay for novel modulators of Apolipoprotein B
$682,895Steven A Farber · Carnegie Institution Of Washington, D.C. · R01 · FY2018 · DK
It's a tug of war: structure, consequences, and inhibition of CXCR4 and ACKR3 responses to lymphocyte chemoattractant CXCL12
$682,876Tracy M Handel · University Of California, San Diego · R01 · FY2022 · AI
Development and validation of a high-throughput MicroED-driven platform technology for natural product discovery
$682,864Cassandra Leah Quave · Emory University · R01 · FY2022 · AT
Decoding Astrocyte Signaling in Neural Circuitry with Novel Computational Modeling and Analytical Tools
$682,861Yue Wang · Virginia Polytechnic Inst And St Univ · R01 · FY2025 · MH
Mechanisms of Transformation by TAL1/SCL in Thymic Malignancy
$682,792A Thomas Look · Dana-Farber Cancer Inst · P01 · FY2014 · CA
Defining trajectories of dynamic biomarkers for C9ORF72 repeat expansion carriers
$682,690Suzee Eurie Lee · University Of California, San Francisco · R01 · FY2022 · AG
Defining trajectories of dynamic biomarkers for C9ORF72 repeat expansion carriers
$682,690Suzee Eurie Lee · University Of California, San Francisco · R01 · FY2021 · AG
Synthetic environmental peptide libraries as a source of novel antibiotics
$682,686Sean F Brady · Hackensack University Medical Center · U19 · FY2021 · AI
Mitogenic and Oncogenic Regulation of ERK/RSK Signaling
$682,680John Blenis · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · CA
Mitogenic and Oncogenic Regulation of ERK/RSK Signaling
$682,680John Blenis · Weill Medical Coll Of Cornell Univ · R01 · FY2020 · CA
Mitogenic and Oncogenic Regulation of ERK/RSK Signaling
$682,680John Blenis · Weill Medical Coll Of Cornell Univ · R01 · FY2019 · CA
Mitogenic and Oncogenic Regulation of ERK/RSK Signaling
$682,680John Blenis · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · CA
Novel Antifungals by Engineering the AbA NRPS gene
$682,676Ake P Elhammer · Aureogen Biosciences, Inc. · R44 · FY2008 · AI
Development of p300/CBP histone acetyltransferase inhibitors for oncogene-driven cancers
$682,670William C Hahn · Broad Institute, Inc. · R01 · FY2022 · CA
Network-based algorithms for target identification and drug repositioning from genetic associations
$682,666Casey S Greene · University Of Pennsylvania · R01 · FY2019 · HG
Rabbit model for cystic fibrosis
$682,527Fei Sun · Wayne State University · R01 · FY2016 · HL
The Role of Aberrant Histone Acetylation in the Pathogenesis of Parkinsonâs Disease and Related Synucleinopathies.
$682,493Frank Soldner · Albert Einstein College Of Medicine · R01 · FY2024 · NS
Genotype-guided therapy for atrial fibrillation
$682,491Dawood Darbar · University Of Illinois At Chicago · R01 · FY2024 · HL